Search tips
Search criteria 


Logo of skullbasesurgInstructions for AuthorsSubscribe to Skull BaseAbout Skull BaseEditorial BoardThieme Medical PublishingSkull Base An Interdisciplinary Approach ...
Skull base surgery. 1996 April; 6(2): 69–76.
PMCID: PMC1656584

Targeted Infusions of Supradose Cisplatin With Systemic Neutralization for Carcinomas Invading the Temporal Bone


In an attempt to improve the dismal prognosis for patients with advanced cancer involving the temporal bone, a regional chemotherapy technique was piloted as part of the multimodality therapy for such patients. Rapid supradose cisplatin infusions selectively delivered to the lesion were given to 14 patients with carcinoma involving the temporal bone. Concurrent systemic cisplatin neutralization was achieved with sodium thiosulfate which permitted the use of cisplatin dose intensity regimens equivalent to fivefold the conventional amount. Four patients received chemotherapy alone, four had concomitant irradiation, and six had subsequent irradiation and/or temporal bone surgery. All patients tolerated the chemotherapy without significant complications or toxicity.

All three of the patients with previously untreated disease responded to chemotherapy (2 Crs, 1 PR); three of the seven patients with recurrent disease responded to chemotherapy; and all four patients treated with chemoradiation had a complete response (including one patient with recurrent disease). The median follow-up time was 19 months (range, 5 to 63 months). Nine of the 14 patients are alive, including the 4 who were treated with targeted chemoradiation.

The use of targeted high-dose chemotherapy for patients with malignant skull base lesions offers hope for improved outcome, particularly when this regimen is given simultaneously with radiation.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (2.9M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Images in this article

Click on the image to see a larger version.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Robbins KT, Storniolo AM, Kerber C, Seagren S, Berson A, Howell SB. Rapid superselective high-dose cisplatin infusion for advanced head and neck malignancies. Head Neck. 1992 Sep-Oct;14(5):364–371. [PubMed]
  • Robbins KT, Storniolo AM, Kerber C, Vicario D, Seagren S, Shea M, Hanchett C, Los G, Howell SB. Phase I study of highly selective supradose cisplatin infusions for advanced head and neck cancer. J Clin Oncol. 1994 Oct;12(10):2113–2120. [PubMed]
  • Robbins KT, Pellitteri PK, Harris JP, Hanchett C, Kerber C, Vicario D. Highly selective infusions of supradose Cisplatin for cranial base malignancies. Skull Base Surg. 1994;4(3):122–126. [PMC free article] [PubMed]
  • Robbins KT, Vicario D, Seagren S, Weisman R, Pellitteri P, Kerber C, Orloff L, Los G, Howell SB. A targeted supradose cisplatin chemoradiation protocol for advanced head and neck cancer. Am J Surg. 1994 Nov;168(5):419–422. [PubMed]
  • Prasad S, Janecka IP. Efficacy of surgical treatments for squamous cell carcinoma of the temporal bone: a literature review. Otolaryngol Head Neck Surg. 1994 Mar;110(3):270–280. [PubMed]
  • Howell SB, Taetle R. Effect of sodium thiosulfate on cis-dichlorodiammineplatinum(II) toxicity and antitumor activity in L1210 leukemia. Cancer Treat Rep. 1980 Apr-May;64(4-5):611–616. [PubMed]
  • Howell SB. Improving the therapeutic index of intra-arterial cisplatin chemotherapy. Eur J Cancer Clin Oncol. 1989 May;25(5):775–776. [PubMed]
  • Howell SB, Pfeifle CL, Wung WE, Olshen RA, Lucas WE, Yon JL, Green M. Intraperitoneal cisplatin with systemic thiosulfate protection. Ann Intern Med. 1982 Dec;97(6):845–851. [PubMed]
  • Sartorelli AC. Therapeutic attack of hypoxic cells of solid tumors: presidential address. Cancer Res. 1988 Feb 15;48(4):775–778. [PubMed]
  • Tannock IF, Rotin D. Acid pH in tumors and its potential for therapeutic exploitation. Cancer Res. 1989 Aug 15;49(16):4373–4384. [PubMed]
  • Sinclair WK. Hydroxyurea: effects on Chinese hamster cells grown in culture. Cancer Res. 1967 Feb;27(2):297–308. [PubMed]
  • Douple EB, Richmond RC. Platinum complexes as radiosensitizers of hypoxic mammalian cells. Br J Cancer Suppl. 1978 Jun;3:98–102. [PubMed]
  • Muggia FM, Glatstein E. Summary of investigations on platinum compounds and radiation interactions. Int J Radiat Oncol Biol Phys. 1979 Aug;5(8):1407–1409. [PubMed]
  • Alvarez MV, Cobreros G, Heras A, Lopez Zumel MC. Studies on cis-dichlorodiammineplatinum (II) as a radiosensitizer. Br J Cancer Suppl. 1978 Jun;3:68–72. [PubMed]
  • Zák M, Drobník J. Effect of cis-dichlorodiamine platinum (II) on the post-irradiation lethality in mice after irradiation with X-rays. Strahlentherapie. 1971 Jul;142(1):112–115. [PubMed]
  • Slotman GJ, Cummings FJ, Glicksman AR, Doolittle CL, Leone LA. Preoperative simultaneously administered cis-platinum plus radiation therapy for advanced squamous cell carcinoma of the head and neck. Head Neck Surg. 1986 Jan-Feb;8(3):159–164. [PubMed]
  • Murthy AK, Taylor SG, 4th, Showel J, Caldarelli DD, Hutchinson JC, Jr, Holinger LD, Witt TR, Hoover S. Treatment of advanced head and neck cancer with concomitant radiation and chemotherapy. Int J Radiat Oncol Biol Phys. 1987 Dec;13(12):1807–1813. [PubMed]
  • Marcial VA, Pajak TF, Mohiuddin M, Cooper JS, al Sarraf M, Mowry PA, Curran W, Crissman J, Rodríguez M, Vélez-García E. Concomitant cisplatin chemotherapy and radiotherapy in advanced mucosal squamous cell carcinoma of the head and neck. Long-term results of the Radiation Therapy Oncology Group study 81-17. Cancer. 1990 Nov 1;66(9):1861–1868. [PubMed]
  • Taylor SG, 4th, Murthy AK, Caldarelli DD, Showel JL, Kiel K, Griem KL, Mittal BB, Kies M, Hutchinson JC, Jr, Holinger LD, et al. Combined simultaneous cisplatin/fluorouracil chemotherapy and split course radiation in head and neck cancer. J Clin Oncol. 1989 Jul;7(7):846–856. [PubMed]
  • Wendt TG, Hartenstein RC, Wustrow TP, Lissner J. Cisplatin, fluorouracil with leucovorin calcium enhancement, and synchronous accelerated radiotherapy in the management of locally advanced head and neck cancer: a phase II study. J Clin Oncol. 1989 Apr;7(4):471–476. [PubMed]
  • Adelstein DJ, Sharan VM, Earle AS, Shah AC, Vlastou C, Haria CD, Carter SG, Damm C, Hines JD. Long-term results after chemoradiotherapy for locally confined squamous-cell head and neck cancer. Am J Clin Oncol. 1990 Oct;13(5):440–447. [PubMed]
  • Al-Sarraf M, Pajak TF, Marcial VA, Mowry P, Cooper JS, Stetz J, Ensley JF, Velez-Garcia E. Concurrent radiotherapy and chemotherapy with cisplatin in inoperable squamous cell carcinoma of the head and neck. An RTOG Study. Cancer. 1987 Jan 15;59(2):259–265. [PubMed]
  • Vokes EE, Weichselbaum RR. Concomitant chemoradiotherapy: rationale and clinical experience in patients with solid tumors. J Clin Oncol. 1990 May;8(5):911–934. [PubMed]
  • al-Sarraf M, Pajak TF, Cooper JS, Mohiuddin M, Herskovic A, Ager PJ. Chemo-radiotherapy in patients with locally advanced nasopharyngeal carcinoma: a radiation therapy oncology group study. J Clin Oncol. 1990 Aug;8(8):1342–1351. [PubMed]
  • Merlano M, Grimaldi A, Benasso M, Bacigalupo A, Toma S, Scarpati D, Corvò R, Santelli A, Garaventa G, Rosso R. Alternating cisplatin-5-fluorouracil and radiotherapy in head and neck cancer. Am J Clin Oncol. 1988 Oct;11(5):538–542. [PubMed]

Articles from Skull Base Surgery are provided here courtesy of Thieme Medical Publishers